期刊
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
卷 9, 期 8, 页码 910-918出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/ueg2.12146
关键词
complications; eosinophilic oesophagitis; oesophagus; proton pump inhibitors; treatment
This study assessed the effectiveness of PPIs in treating EoE and evaluated whether patients were treated according to guidelines. Results showed that high-dose PPI treatment was effective in half of EoE patients, but conflicting symptomatic and histological responses were common. Complications were rare when PPIs were started, and one-third of patients were not rebiopsied as recommended.
Background Proton pump inhibitors (PPIs) are often the first drug of choice in the treatment of eosinophilic oesophagitis (EoE), and in Denmark 8 weeks of high-dose PPI therapy is recommended as first-line treatment followed by rebiopsying, reflecting international recommendations. Aims To assess the population-based effectiveness of PPIs in the treatment of EoE and evaluate whether patients were treated and followed according to the regional guideline. Methods This is a retrospective, registry-based, DanEoE cohort study of 236 adult EoE patients diagnosed between 2007 and 2017 in the North Denmark Region. After patient file revision, the EoE diagnosis was defined according to the AGREE 2 consensus. Symptomatic PPI response was defined as complete symptom resolution and histological remission (<15 eosinophils per high-power field). Results PPI treatment was initiated in 92% of the EoE patients. High- and low-dose PPIs were prescribed in 55% and 45% of the cases, respectively. When treated with high-dose PPIs, 68% of the patients were completely symptom-free, and 49% were in histological remission. In 39% of high-dose PPI-treated patients, the symptomatic and histological responses were conflicting. While treated with PPIs, complications were rare, with High-dose PPI treatment was effective in half of the EoE patients started on PPIs, but conflicting symptomatic and histological PPI responses were common. Complications were rare when PPIs were started. One-third of the patients were not rebiopsied as recommended.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据